Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?
Saved in:
Main Authors: | Ann T. Sweeney, MD, Michael A. Blake, MB, BCh, Sina Jasim, MD, MPH, Karel Pacak, MD, PhD, DSc |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060524001329 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two Cases of Composite Pheochromocytoma-Ganglioneuromas With Plasma Metanephrine Levels in the Subclinical Range Pheochromocytoma-Ganglioneuroma
by: Mayssam El Najjar, MD, et al.
Published: (2025-01-01) -
Sex differences in presentation of pheochromocytoma and paraganglioma
by: Nora Azin Ali, et al.
Published: (2025-01-01) -
SDHB-Associated Paraganglioma in a Pediatric Patient and Literature Review on Hereditary Pheochromocytoma-Paraganglioma Syndromes
by: Heather Choat, et al.
Published: (2014-01-01) -
Simultaneous Pheochromocytoma, Paraganglioma, and Papillary Thyroid Carcinoma without Known Mutation
by: Lorena Rasquin, et al.
Published: (2018-01-01) -
Misdiagnosis and analysis of clinical characteristics in patients with giant cystic pheochromocytoma/paraganglioma
by: Yue Zhang, et al.
Published: (2024-12-01)